These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 31598934

  • 1. [Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome].
    Zhou X, Jin H, Mu Q, Sheng L, Lai B, Zhu H, Ouyang G.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct 10; 36(10):953-956. PubMed ID: 31598934
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).
    Yao CY, Hou HA, Lin TY, Lin CC, Chou WC, Tseng MH, Chiang YC, Liu MC, Liu CW, Kuo YY, Wu SJ, Liao XW, Lin CT, Ko BS, Chen CY, Hsu SC, Li CC, Huang SY, Yao M, Tang JL, Tsay W, Liu CY, Tien HF.
    Oncotarget; 2016 Sep 27; 7(39):63177-63188. PubMed ID: 27527853
    [Abstract] [Full Text] [Related]

  • 4. [Clinical Characteristics and Karyotype Analysis of Myelodysplastic Syndrome Patients with TP53 mutation].
    Zhou XY, Ouyang GF, Mu QT, Sheng LX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun 27; 27(3):872-876. PubMed ID: 31204947
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome].
    Zhao F, Wang KL, Qin YT, Nilupar T, Patiguli A, Jiang M, Hao JP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec 27; 29(6):1864-1868. PubMed ID: 34893124
    [Abstract] [Full Text] [Related]

  • 7. [Clinical characteristics and prognosis of patients with myelodysplastic syndrome with a bone marrow nucleated erythroid cell proportion of greater than or equal to 50].
    Zeng YP, Li B, Qin TJ, Xu ZF, Qu SJ, Pan LJ, Gao QY, Jiao M, Wu JY, Wang HJ, Li CW, Ja YJ, Sun Q, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul 14; 45(7):651-659. PubMed ID: 39231769
    [Abstract] [Full Text] [Related]

  • 8. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
    Zhang WW, Zhang YL, Ren CC, Wu TK, Liu B.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb 14; 32(1):176-183. PubMed ID: 38387918
    [Abstract] [Full Text] [Related]

  • 9. Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.
    Tefferi A, Lasho TL, Patnaik MM, Saeed L, Mudireddy M, Idossa D, Finke C, Ketterling RP, Pardanani A, Gangat N.
    Am J Hematol; 2017 Dec 14; 92(12):1311-1317. PubMed ID: 28875545
    [Abstract] [Full Text] [Related]

  • 10. Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.
    Jiang L, Luo Y, Zhu S, Wang L, Ma L, Zhang H, Shen C, Yang W, Ren Y, Zhou X, Mei C, Ye L, Xu W, Yang H, Lu C, Jin J, Tong H.
    Cancer Sci; 2020 Feb 14; 111(2):580-591. PubMed ID: 31804030
    [Abstract] [Full Text] [Related]

  • 11. Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.
    Nazha A, Bejar R.
    Curr Hematol Malig Rep; 2017 Oct 14; 12(5):461-467. PubMed ID: 28844082
    [Abstract] [Full Text] [Related]

  • 12. Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.
    Ren Y, Lang W, Mei C, Luo Y, Ye L, Wang L, Zhou X, Xu G, Ma L, Jin J, Tong H.
    Hematol Oncol; 2023 Feb 14; 41(1):159-166. PubMed ID: 36316121
    [Abstract] [Full Text] [Related]

  • 13. Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype.
    Wang W, Routbort MJ, Tang Z, Ok CY, Patel KP, Daver N, Garcia-Manero G, Medeiros LJ, Wang SA.
    Eur J Haematol; 2017 Dec 14; 99(6):536-543. PubMed ID: 28926144
    [Abstract] [Full Text] [Related]

  • 14. SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome.
    Falantes JF, Márquez-Malaver FJ, Carrillo E, Culebras MG, Morales R, Prats C, Vargas MT, Caballero T, Rodríguez-Arbolí E, Espigado I, Pérez-Simón JA.
    Clin Lymphoma Myeloma Leuk; 2022 Dec 14; 22(12):e1059-e1066. PubMed ID: 36117041
    [Abstract] [Full Text] [Related]

  • 15. Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
    Hou HA, Tsai CH, Lin CC, Chou WC, Kuo YY, Liu CY, Tseng MH, Peng YL, Liu MC, Liu CW, Liao XW, Lin LI, Yao M, Tang JL, Tien HF.
    Blood Cancer J; 2018 Apr 04; 8(4):39. PubMed ID: 29618722
    [Abstract] [Full Text] [Related]

  • 16. A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS.
    Gu S, Xia J, Tian Y, Zi J, Ge Z.
    BMC Cancer; 2021 Feb 06; 21(1):134. PubMed ID: 33549060
    [Abstract] [Full Text] [Related]

  • 17. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
    Zhu Y, Li X, Chang C, Xu F, He Q, Guo J, Tao Y, Liu Y, Liu L, Shi W.
    Leuk Res; 2016 May 06; 44():8-16. PubMed ID: 26970172
    [Abstract] [Full Text] [Related]

  • 18. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis.
    Loghavi S, Al-Ibraheemi A, Zuo Z, Garcia-Manero G, Yabe M, Wang SA, Kantarjian HM, Yin CC, Miranda RN, Luthra R, Medeiros LJ, Bueso-Ramos CE, Khoury JD.
    Br J Haematol; 2015 Oct 06; 171(1):91-9. PubMed ID: 26123119
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes.
    Maurya N, Mohanty P, Dhangar S, Panchal P, Jijina F, Mathan SLP, Shanmukhaiah C, Madkaikar M, Vundinti BR.
    Sci Rep; 2022 Apr 08; 12(1):5925. PubMed ID: 35396491
    [Abstract] [Full Text] [Related]

  • 20. Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes.
    Melody M, Al Ali N, Zhang L, Ramadan H, Padron E, Sallman D, Sweet K, Lancet J, List A, Bennett JM, Komrokji R.
    Clin Lymphoma Myeloma Leuk; 2020 May 08; 20(5):324-328. PubMed ID: 32044274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.